The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
The supply of these goods is set to commence within the first quarter of FY26
The order strengthens the company’s position in the East African market
Subscribe To Our Newsletter & Stay Updated
